Marwan Saleh D. Albalawi

Role of Anti-VEGF (Bevacizumab) in Management of Neovascular Glaucoma: A Review

Abdulrahman Arshed N. Alharfy, Marwan Saleh D. Albalawi, Abdulmajeed Mousa Alzahrani, Ruby Naif M. Alsubaie, Amani Ahmad S. Albalawi, Waad Ali Alkaabneh, Abdullah Ibrahim Altidlawi, Amal Nafea J. Alharbi, Afnan Mohammed H. Almutairi & Rola Ali S. Alotabi · Journal of Pharmaceutical Research International · 2021

Neovascular glaucoma (NVG) is an aggressive type of glaucoma, which often results in poor visual outcomes. Antivascular endothelial growth factor is frequently used for various conditions in which VEGF release is induced in response to retinal ischemia. Bevacizumab is a humanized...

Open access Research Article 10.9734/jpri/2021/v33i40A32237

Surgical Treatment of Adult Moyamoya Disease In Saudi Arabia: A Review Article

Bedour Eid H. Alatawi, Faisal Saeed A. Al-Ghamdi, Muath Sulaiman G. Alhamdi, Raghad Dhafer E. ALamri, Lena Defallah G. Alzahrani, Norah Majed Albalawi, Sultan Suliman Q. Al-Ruwaili, Khaled Abdullah S. Alasmari, Marwan Saleh D. Albalawi & Ghadeer Abdullah Albalawi · Journal of Pharmaceutical Research International · 2021

Moyamoya disease (MMD) is an isolated chronic, usually bilateral, vasculopathy disease of undetermined etiology. The clinical presentations of MMD include TIA, ischemic stroke, hemorrhagic stroke, seizures, headache, and cognitive impairment. Intra- and extra-cranial revasculariz...

Open access Research Article 10.9734/jpri/2021/v33i37A31990